Found: 34
Select item for more details and to access through your institution.
Polatuzumab vedotin, venetoclax, and an anti‐CD20 monoclonal antibody in relapsed/refractory B‐cell non‐Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1281, doi. 10.1002/ajh.27341
- By:
- Publication type:
- Article
Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 449, doi. 10.1002/ajh.26809
- By:
- Publication type:
- Article
A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 5, p. 536, doi. 10.1002/ajh.23684
- By:
- Publication type:
- Article
A new method to detect loss of heterozygosityusing cohort heterozygosity comparisons.
- Published in:
- BMC Cancer, 2010, v. 10, p. 195, doi. 10.1186/1471-2407-10-195
- By:
- Publication type:
- Article
How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00996-x
- By:
- Publication type:
- Article
FLT3‐ITD positive acute myeloid leukemia: A retrospective analysis of the role of allogeneic transplant and allelic ratio in patient management.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2018, v. 14, n. 6, p. 426, doi. 10.1111/ajco.12827
- By:
- Publication type:
- Article
Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2014, v. 10, n. 3, p. 246, doi. 10.1111/ajco.12188
- By:
- Publication type:
- Article
Post-transplant hepatosplenic T-cell lymphoma successfully treated with hyperCVAD regimen.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 4, p. 330, doi. 10.1002/ajh.21062
- By:
- Publication type:
- Article
Letter to the editor: Fludarabine-induced cytogenetic remission in prolymphocytic leukemia.
- Published in:
- American Journal of Hematology, 1992, v. 40, n. 1, p. 71, doi. 10.1002/ajh.2830400117
- By:
- Publication type:
- Article
Prognostic markers in core-binding factor AML and improved survival with multiple consolidation cycles of intermediate-/ high-dose cytarabine.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 2, p. 174, doi. 10.1111/ejh.13089
- By:
- Publication type:
- Article
Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 2, p. 97, doi. 10.1111/ejh.12793
- By:
- Publication type:
- Article
The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization.
- Published in:
- Hematological Oncology, 2006, v. 24, n. 3, p. 159, doi. 10.1002/hon.784
- By:
- Publication type:
- Article
Chronic lymphocytic leukaemia Australasian consensus practice statement.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 9, p. 1678, doi. 10.1111/imj.16207
- By:
- Publication type:
- Article
Author reply.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Front‐line management of indolent non‐Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphoma.
- Published in:
- Internal Medicine Journal, 2019, v. 49, n. 9, p. 1070, doi. 10.1111/imj.14268
- By:
- Publication type:
- Article
Front‐line management of non‐Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
- Published in:
- Internal Medicine Journal, 2019, v. 49, n. 4, p. 422, doi. 10.1111/imj.14113
- By:
- Publication type:
- Article
Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil.
- Published in:
- Internal Medicine Journal, 2017, v. 47, p. 5, doi. 10.1111/imj.13493
- By:
- Publication type:
- Article
Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome.
- Published in:
- PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0227455
- By:
- Publication type:
- Article
Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. 790, doi. 10.1111/bjh.18306
- By:
- Publication type:
- Article
Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 5, p. 1209, doi. 10.1111/bjh.17994
- By:
- Publication type:
- Article
Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 2, p. 328, doi. 10.1111/bjh.14063
- By:
- Publication type:
- Article
A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 5, p. 618, doi. 10.1111/bjh.13086
- By:
- Publication type:
- Article
A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R- ITP1000 study).
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 243, doi. 10.1111/bjh.13029
- By:
- Publication type:
- Article
A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study)
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13029
- By:
- Publication type:
- Article
Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patients.
- Published in:
- Annals of Hematology, 2008, v. 87, n. 9, p. 727, doi. 10.1007/s00277-008-0488-6
- By:
- Publication type:
- Article
Granulocyte colony stimulating factor in the management of chronic neutropenia.
- Published in:
- Medical Journal of Australia, 1992, v. 156, n. 10, p. 729, doi. 10.5694/j.1326-5377.1992.tb121518.x
- By:
- Publication type:
- Article
High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to non-hodgkin's lymphoma.
- Published in:
- Genes, Chromosomes & Cancer, 2013, v. 52, n. 5, p. 467, doi. 10.1002/gcc.22044
- By:
- Publication type:
- Article
Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma.
- Published in:
- Genes, Chromosomes & Cancer, 2011, v. 50, n. 5, p. 313, doi. 10.1002/gcc.20856
- By:
- Publication type:
- Article
The Perspectives of Haematological Cancer Patients on Tissue Banking.
- Published in:
- Oncology & Therapy, 2016, v. 4, n. 1, p. 91, doi. 10.1007/s40487-016-0019-x
- By:
- Publication type:
- Article
Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.
- Published in:
- Nephrology Dialysis Transplantation, 2015, v. 30, n. 10, p. 1774, doi. 10.1093/ndt/gfv260
- By:
- Publication type:
- Article
Incidence and nature of CD20-negative relapses following rituximab therapy in aggressive B-cell non-Hodgkin's lymphoma: a retrospective review.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 2, p. 412, doi. 10.1046/j.1365-2141.2002.03843.x
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- British Journal of Haematology, 2001, v. 112, n. 1, p. 256, doi. 10.1046/j.1365-2141.2001.02652-2.x
- By:
- Publication type:
- Article
Molecular remission without blood product support using all-trans retinoic acid (ATRA) induction and combined arsenic trioxide/ATRA consolidation in a Jehovah's Witness with de novo acute promyelocytic leukaemia.
- Published in:
- British Journal of Haematology, 2000, v. 111, n. 4, p. 1103, doi. 10.1046/j.1365-2141.2000.02480.x
- By:
- Publication type:
- Article